Arabic Arabic English English French French German German
dark

Ibrutinib found to be effective treatment for difficult-to-treat forms of hairy cell leukemia

The oral targeted therapy drug ibrutinib is an effective treatment option for high-risk hairy cell leukemia, according to a new study conducted by researchers at The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC—James). Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Kids with longer seated lunch times eat more fruit and vegetables

Next Post

Thailand to join COVAX, acknowledging low vaccine supply

Related Posts
Total
0
Share